AEON Biopharma, Inc. (AEON)

NYSEAMERICAN: AEON · IEX Real-Time Price · USD

7.20

+0.18 (2.56%)

Dec 29, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020
Selling, General & Admin	13.68	11.15	0
Research & Development	34.75	25.73	0
Other Operating Expenses	0	28.97	0
Operating Expenses	48.43	65.85	0
Operating Income	-48.43	-65.85	-0
Other Expense / Income	4.13	-10.21	-
Pretax Income	-52.56	-55.64	-0
Net Income	-52.56	-55.64	-0
Shares Outstanding (Basic)	139	126	6
Shares Outstanding (Diluted)	139	126	6
Shares Change	9.96%	2004.21%	-
EPS (Basic)	-0.38	-0.44	-
EPS (Diluted)	-0.38	-0.44	-
Free Cash Flow	-35.89	-28.6	0
Free Cash Flow Per Share	-0.26	-0.23	-
EBITDA	-52.49	-55.63	-0
Depreciation & Amortization	0.07	0	0
EBIT	-52.56	-55.64	-0

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).